Evaluation of reward processes in an animal model of depression

[1]  A. Devries,et al.  Role of IL-1 in Poststroke Depressive-like Behavior in Mice , 2006, Biological Psychiatry.

[2]  A. Becker,et al.  Cell Proliferation is Influenced by Bulbectomy and Normalized by Imipramine Treatment in a Region-Specific Manner , 2006, Neuropsychopharmacology.

[3]  I. Gottesman,et al.  Psychiatric endophenotypes and the development of valid animal models , 2006, Genes, brain, and behavior.

[4]  R. Weiss,et al.  The Effects of Chronic Fluoxetine Treatment on Chronic Mild Stress-Induced Cardiovascular Changes and Anhedonia , 2006, Biological Psychiatry.

[5]  B. Leonard,et al.  The olfactory bulbectomised rat as a model of depression , 2005, Neuroscience & Biobehavioral Reviews.

[6]  Athina Markou,et al.  Psychostimulant withdrawal as an inducing condition in animal models of depression , 2005, Neuroscience & Biobehavioral Reviews.

[7]  R. Wise.  Forebrain substrates of reward and motivation , 2005, The Journal of comparative neurology.

[8]  A. Zharkovsky,et al.  Impaired fear memory and decreased hippocampal neurogenesis following olfactory bulbectomy in rats , 2005, The European journal of neuroscience.

[9]  D. Slattery,et al.  The GABAB Receptor-Positive Modulator GS39783 and the GABAB Receptor Agonist Baclofen Attenuate the Reward-Facilitating Effects of Cocaine: Intracranial Self-Stimulation Studies in the Rat , 2005, Neuropsychopharmacology.

[10]  Simon J Graham,et al.  Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. , 2005, Archives of general psychiatry.

[11]  E. Nestler.  Is there a common molecular pathway for addiction? , 2005, Nature Neuroscience.

[12]  Olga V. Demler,et al.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[13]  P. Deldin,et al.  Reduced Sustained Brain Activity During Processing of Positive Emotional Stimuli in Major Depression , 2005, Biological Psychiatry.

[14]  H. Westenberg,et al.  Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: An in vivo microdialysis study , 2005, Biological Psychiatry.

[15]  D. Pizzagalli,et al.  Toward an objective characterization of an anhedonic phenotype: A signal-detection approach , 2005, Biological Psychiatry.

[16]  S. Mague,et al.  Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats , 2005, Biological Psychiatry.

[17]  D. Slattery,et al.  GABAB Receptor Antagonist-Mediated Antidepressant-Like Behavior Is Serotonin-Dependent , 2005, Journal of Pharmacology and Experimental Therapeutics.

[18]  G. Debonnel,et al.  Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study , 2005, Psychopharmacology.

[19]  D. Bartsch,et al.  Stress-Induced Anhedonia in Mice is Associated with Deficits in Forced Swimming and Exploration , 2004, Neuropsychopharmacology.

[20]  W. Drevets,et al.  Discovering Endophenotypes for Major Depression , 2004, Neuropsychopharmacology.

[21]  JaneR . Taylor,et al.  Locomotor sensitization to cocaine in rats with olfactory bulbectomy , 2004, Synapse.

[22]  A. Young,et al.  Recognition accuracy and response bias to happy and sad facial expressions in patients with major depression. , 2004, Neuropsychology.

[23]  J. Cryan,et al.  In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice , 2004, Molecular Psychiatry.

[24]  P. Holmes,et al.  Dopamine overflow is increased in olfactory bulbectomized rats: an in vivo microdialysis study , 2004, Physiology & Behavior.

[25]  C. Kornetsky.  Brain-stimulation reward, morphine-induced oral stereotypy, and sensitization: implications for abuse , 2004, Neuroscience & Biobehavioral Reviews.

[26]  J. Kelly,et al.  A review of the relevance and validity of olfactory bulbectomy as a model of depression , 2003, Clinical Neuroscience Research.

[27]  P. Holmes,et al.  Herpes virus-mediated preproenkephalin gene transfer in the ventral striatum mimics behavioral changes produced by olfactory bulbectomy in rats , 2003, Brain Research.

[28]  D. Hoyer,et al.  Withdrawal from chronic amphetamine induces Depressive-Like behavioral effects in rodents , 2003, Biological Psychiatry.

[29]  Daniela Popa,et al.  Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Wise.  Brain Reward Circuitry Insights from Unsensed Incentives , 2002, Neuron.

[31]  J. Crystal,et al.  Intravenous self‐administration of amphetamine is increased in a rat model of depression , 2002, Synapse.

[32]  M A Mintun,et al.  The hippocampus and depression , 2002, European Psychiatry.

[33]  C. Naranjo,et al.  Probing brain reward system function in major depressive disorder: altered response to dextroamphetamine. , 2002, Archives of general psychiatry.

[34]  Athina Markou,et al.  Assessing antidepressant activity in rodents: recent developments and future needs. , 2002, Trends in pharmacological sciences.

[35]  V. Arango,et al.  Serotonin brain circuits involved in major depression and suicide. , 2002, Progress in brain research.

[36]  C. Naranjo,et al.  The role of the brain reward system in depression , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[37]  W. Drevets.  Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders , 2001, Current Opinion in Neurobiology.

[38]  H. Stock,et al.  Gender and gonadal hormone effects in the olfactory bulbectomy animal model of depression , 2000, Pharmacology Biochemistry and Behavior.

[39]  J. Kelly,et al.  Olfactory Bulbectomy Provokes a Suppression of Interleukin-1β and Tumour Necrosis Factor-α Production in Response to an in vivo Challenge with Lipopolysaccharide: Effect of Chronic Desipramine Treatment , 1999, Neuroimmunomodulation.

[40]  Trevor R. Norman,et al.  Onset of the Effects of the 5-HT1A Antagonist, WAY-100635, Alone, and in Combination With Paroxetine, on Olfactory Bulbectomy and 8-OH-DPAT–Induced Changes in the Rat , 1999, Pharmacology Biochemistry and Behavior.

[41]  Trevor R. Norman,et al.  Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected? , 1998, European journal of pharmacology.

[42]  G. Koob,et al.  Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis , 1998, Neuropsychopharmacology.

[43]  K. Touzani,et al.  Electrical self-stimulation in the central amygdaloid nucleus after ibotenic acid lesion of the lateral hypothalamus , 1998, Behavioural Brain Research.

[44]  R. Hen,et al.  Insights into the Neurobiology of Impulsive Behavior from Serotonin Receptor Knockout Mice , 1997, Annals of the New York Academy of Sciences.

[45]  P. Willner.  Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation , 1997, Psychopharmacology.

[46]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[47]  J. Kelly,et al.  The olfactory bulbectomized rat as a model of depression: an update. , 1997, Pharmacology & therapeutics.

[48]  D. Calcagnetti,et al.  Olfactory bulbectomy distrupts the expression of cocaine-induced conditioned place preference , 1996, Physiology & Behavior.

[49]  N. Varney,et al.  Psychopharmacology: The Fourth Generation of Progress. , 1996 .

[50]  D. Calcagnetti,et al.  Olfactory bulbectomy disrupts the expression of cocaine-induced conditioned place preference. , 1996, Physiology & behavior.

[51]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[52]  P. Piazza,et al.  Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration. A microdialysis study , 1993, Brain Research.

[53]  A. Sahgal.  Behavioural neuroscience : a practical approach , 1993 .

[54]  Martin H. Teicher,et al.  Olfactory bulbectomy as a model for agitated hyposerotonergic depression , 1992, Brain Research.

[55]  G. Koob,et al.  Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations , 1992, Physiology & Behavior.

[56]  P. Kalivas,et al.  Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity , 1991, Brain Research Reviews.

[57]  R. Wise,et al.  Brain mechanisms of drug reward and euphoria. , 1985, Psychiatric medicine.

[58]  R. Kuczenski,et al.  Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment , 1983, Brain Research.

[59]  R. Wise,et al.  Action of drugs of abuse on brain reward systems: An update with specific attention to opiates , 1982, Pharmacology Biochemistry and Behavior.

[60]  A. Phillips,et al.  Increased intracranial self-stimulation in rats after long-term administration of desipramine. , 1981, Science.

[61]  C. Kornetsky,et al.  Euphorigenic drugs: effects on the reward pathways of the brain. , 1979, Federation proceedings.

[62]  A. Phillips,et al.  Monoamine involvement in hippocampal self-stimulation , 1977, Brain Research.